Related Experiment Video
Updated: Oct 1, 2025
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
Triptolide Shows High Sensitivity and Low Toxicity Against Acute Myeloid Leukemia Cell Lines Through Inhibiting
1Jiangsu Key Laboratory for Functional Substance of Chinese Medicine, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.
Abstract:
Triptolide exhibits superior and broad-spectrum antitumor activity. However, the narrow safety window caused by the toxicity of triptolide limits its clinical applications. Although several characterized targets for triptolide are reported, the association between triptolide and its targets in cancer therapy is not fully understood. Here, we show that acute myeloid leukemia (AML) cell lines are sensitive to triptolide by constructing an in vitro cell and in vivo xenograft models. Meanwhile, the triptolide-induced hepatotoxicity increases with increasing dosages within the xenograft models. Additionally, the expression levels of WSTF-RPB1 are strongly associated with the sensitivity to triptolide in hematological cancer cells and can be downregulated in a dose and time-dependent manner. Finally, we show that optimizing dosing regimens can achieve the same pharmaceutical effect and reduce toxicity. In summary, this study aims to search for triptolide-sensitive cell lines as well as the underlying molecular mechanisms in order to broaden the safety window of triptolide; thus, increasing its clinical utility.
Insights
Triptolide shows promise against acute myeloid leukemia (AML), but its toxicity is a concern. This study identifies WSTF-RPB1 as a key factor and suggests optimized dosing to improve its cancer therapy safety window.
Area of Science:
- Pharmacology
- Oncology
- Molecular Biology
Background:
- Triptolide possesses broad-spectrum antitumor activity but is limited by significant toxicity.
- The precise molecular targets and mechanisms of triptolide in cancer therapy remain incompletely understood.
Purpose of the Study:
- To investigate triptolide sensitivity in acute myeloid leukemia (AML) models.
- To identify molecular mechanisms underlying triptolide's efficacy and toxicity.
- To explore strategies for optimizing triptolide dosing for enhanced clinical utility.
Main Methods:
- Utilized in vitro cell and in vivo xenograft models to assess triptolide's effects on AML.
- Analyzed the association between WSTF-RPB1 expression and triptolide sensitivity.
- Investigated dose- and time-dependent effects of triptolide on WSTF-RPB1 expression and hepatotoxicity.
Main Results:
- AML cell lines demonstrated sensitivity to triptolide in both in vitro and in vivo models.
- Triptolide-induced hepatotoxicity correlated with increasing dosages in xenograft models.
- WSTF-RPB1 expression levels were strongly linked to triptolide sensitivity in hematological cancers and were dose- and time-dependently downregulated.
Conclusions:
- Optimizing triptolide dosing regimens can maintain therapeutic effects while mitigating toxicity.
- Identifying triptolide-sensitive cell lines and understanding underlying mechanisms can broaden its therapeutic safety window.
- This research paves the way for increased clinical application of triptolide in cancer treatment.
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
01:15Drugs that Stabilize Microtubules
01:10Drugs that Destabilize Microtubules